BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9342994)

  • 1. Estrogen replacement therapy and mortality among older women. The study of osteoporotic fractures.
    Cauley JA; Seeley DG; Browner WS; Ensrud K; Kuller LH; Lipschutz RC; Hulley SB
    Arch Intern Med; 1997 Oct; 157(19):2181-7. PubMed ID: 9342994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen replacement therapy in the elderly.
    Paganini-Hill A
    Zentralbl Gynakol; 1996; 118(5):255-61. PubMed ID: 8701621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risks and benefits of estrogen replacement therapy: Leisure World.
    Paganini-Hill A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():54-62. PubMed ID: 7581589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E phenotype, arterial disease, and mortality among older women: the study of osteoporotic fractures.
    Vogt MT; Cauley JA; Kuller LH
    Genet Epidemiol; 1997; 14(2):147-56. PubMed ID: 9129960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
    Perreault S; Dragomir A; Desgagné A; Blais L; Rossignol M; Blouin J; Moride Y; Ste-Marie LG; Fernandès JC
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy and the risk of incident congestive heart failure: the Cardiovascular Health Study.
    Rea TD; Psaty BM; Heckbert SR; Cushman M; Meilahn E; Olson JL; Lemaitre RN; Smith NL; Sotoodehnia N; Chaves PH
    J Womens Health (Larchmt); 2003 May; 12(4):341-50. PubMed ID: 12804341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women.
    Alexandersen P; Tankó LB; Bagger YZ; Qin G; Christiansen C
    Climacteric; 2006 Apr; 9(2):108-18. PubMed ID: 16698657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen replacement therapy and ovarian cancer.
    Folsom AR; Anderson JP; Ross JA
    Epidemiology; 2004 Jan; 15(1):100-4. PubMed ID: 14712153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmenopausal hormone use and cholecystectomy in a large prospective study.
    Grodstein F; Colditz GA; Stampfer MJ
    Obstet Gynecol; 1994 Jan; 83(1):5-11. PubMed ID: 8272307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
    Grodstein F; Manson JE; Stampfer MJ
    J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.
    Bagger YZ; Tankó LB; Alexandersen P; Hansen HB; Møllgaard A; Ravn P; Qvist P; Kanis JA; Christiansen C
    Bone; 2004 Apr; 34(4):728-35. PubMed ID: 15050905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality following fractures in older women. The study of osteoporotic fractures.
    Browner WS; Pressman AR; Nevitt MC; Cummings SR
    Arch Intern Med; 1996 Jul; 156(14):1521-5. PubMed ID: 8687260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasomotor symptoms and mortality: the Rancho Bernardo Study.
    Svartberg J; von Mühlen D; Kritz-Silverstein D; Barrett-Connor E
    Menopause; 2009; 16(5):888-91. PubMed ID: 19421076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen replacement therapy and urinary tract infections in postmenopausal women aged 45-89.
    Oliveria SA; Klein RA; Reed JI; Cirillo PA; Christos PJ; Walker AM
    Menopause; 1998; 5(1):4-8. PubMed ID: 9689188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking and mortality among older women: the study of osteoporotic fractures.
    Vogt MT; Cauley JA; Scott JC; Kuller LH; Browner WS
    Arch Intern Med; 1996 Mar; 156(6):630-6. PubMed ID: 8629874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body mass index and mortality among older breast cancer survivors in the Study of Osteoporotic Fractures.
    Reeves KW; Faulkner K; Modugno F; Hillier TA; Bauer DC; Ensrud KE; Cauley JA;
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1468-73. PubMed ID: 17627012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased mortality in users of estrogen replacement therapy.
    Henderson BE; Paganini-Hill A; Ross RK
    Arch Intern Med; 1991 Jan; 151(1):75-8. PubMed ID: 1985611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial.
    Ensrud KE; Black DM; Palermo L; Bauer DC; Barrett-Connor E; Quandt SA; Thompson DE; Karpf DB
    Arch Intern Med; 1997 Dec 8-22; 157(22):2617-24. PubMed ID: 9531231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen replacement therapy--something to smile about.
    Paganini-Hill A
    Compend Contin Educ Dent Suppl; 1998; (22):S4-8. PubMed ID: 12089760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.